Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Special Committee on Aging

Executive Summary

Senate on Feb. 24 defeats two amendments to the Senate Committee Funding Resolution that would have eliminated the committee. Proposed by Sens. Cochran (R-Miss.) and Reid (D-Nev.), the amendments were defeated by votes of 68-30 and 56-43. Committee Chairman Pryor (D-Ark.) said the Aging Committee "represents only 1.9% of all Senate committee budgets," and its elimination "would do nothing to help balance the budget or reduce the deficit" but would make the Pharmaceutical Manufacturers Association "the happiest group in town." New Jersey Democratic Sens. Bradley and Lautenberg voted for elimination; Sen. Hatch (R-Utah) opposed it.

Senate on Feb. 24 defeats two amendments to the Senate Committee Funding Resolution that would have eliminated the committee. Proposed by Sens. Cochran (R-Miss.) and Reid (D-Nev.), the amendments were defeated by votes of 68-30 and 56-43. Committee Chairman Pryor (D-Ark.) said the Aging Committee "represents only 1.9% of all Senate committee budgets," and its elimination "would do nothing to help balance the budget or reduce the deficit" but would make the Pharmaceutical Manufacturers Association "the happiest group in town." New Jersey Democratic Sens. Bradley and Lautenberg voted for elimination; Sen. Hatch (R-Utah) opposed it.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS022233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel